Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew L Snow

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Immunological Reviews|July 20, 2010
The power and the promise of restimulation-induced cell death in human immune diseasesAndrew L Snow, Pushpa Pandiyan, Lixin Zheng, et al.
Cell Death & Disease|February 26, 2026
PD-1 protects expanding human T cells from premature restimulation-induced cell death by modulating TCR and CD28 signalingKatherine P Lee, Sara Elster, Benjamin Epstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2014
SAP facilitates recruitment and activation of LCK at NTB-A receptors during restimulation-induced cell deathGil Katz, Scott M Krummey, Sasha E Larsen, et al.
Vaccine|June 14, 2016
Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350Xinle Cui, Zhouhong Cao, Quanyi Chen, et al.
Cellular Immunology|May 31, 2020
Gain-of-function mutations in CARD11 promote enhanced aggregation and idiosyncratic signalosome assemblyJeffrey R Stinson, Batsukh Dorjbal, Dennis P McDaniel, et al.
Transplantation|August 15, 2002
Constitutive activation of Jak/STAT proteins in Epstein-Barr virus-infected B-cell lines from patients with posttransplant lymphoproliferative disorderRonald R Nepomuceno, Andrew L Snow, P Robert Beatty, et al.
Frontiers in Immunology|August 22, 2017
Intrinsic Plasma Cell Differentiation Defects in B Cell Expansion with NF-κB and T Cell Anergy Patient B CellsSwadhinya Arjunaraja, Brent D Nosé, Gauthaman Sukumar, et al.
Cancer Research|August 9, 2003
Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomasRonald R Nepomuceno, Cynthia E Balatoni, Yaso Natkunam, et al.
Cell Death & Disease|April 15, 2021
TIM-3 drives temporal differences in restimulation-induced cell death sensitivity in effector CD8<sup>+</sup> T cells in conjunction with CEACAM1Camille M Lake, Kelsey Voss, Bradly M Bauman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosisAndrew L Snow, Stacie L Lambert, Yasodha Natkunam, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Immunological Reviews|July 20, 2010
The power and the promise of restimulation-induced cell death in human immune diseasesAndrew L Snow, Pushpa Pandiyan, Lixin Zheng, et al.
Cell Death & Disease|February 26, 2026
PD-1 protects expanding human T cells from premature restimulation-induced cell death by modulating TCR and CD28 signalingKatherine P Lee, Sara Elster, Benjamin Epstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2014
SAP facilitates recruitment and activation of LCK at NTB-A receptors during restimulation-induced cell deathGil Katz, Scott M Krummey, Sasha E Larsen, et al.
Vaccine|June 14, 2016
Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350Xinle Cui, Zhouhong Cao, Quanyi Chen, et al.
Cellular Immunology|May 31, 2020
Gain-of-function mutations in CARD11 promote enhanced aggregation and idiosyncratic signalosome assemblyJeffrey R Stinson, Batsukh Dorjbal, Dennis P McDaniel, et al.
Transplantation|August 15, 2002
Constitutive activation of Jak/STAT proteins in Epstein-Barr virus-infected B-cell lines from patients with posttransplant lymphoproliferative disorderRonald R Nepomuceno, Andrew L Snow, P Robert Beatty, et al.
Frontiers in Immunology|August 22, 2017
Intrinsic Plasma Cell Differentiation Defects in B Cell Expansion with NF-κB and T Cell Anergy Patient B CellsSwadhinya Arjunaraja, Brent D Nosé, Gauthaman Sukumar, et al.
Cancer Research|August 9, 2003
Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomasRonald R Nepomuceno, Cynthia E Balatoni, Yaso Natkunam, et al.
Cell Death & Disease|April 15, 2021
TIM-3 drives temporal differences in restimulation-induced cell death sensitivity in effector CD8<sup>+</sup> T cells in conjunction with CEACAM1Camille M Lake, Kelsey Voss, Bradly M Bauman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosisAndrew L Snow, Stacie L Lambert, Yasodha Natkunam, et al.
Pageof 9